IRIS PubliCatt

Daniele, Antonio
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 3.557
NA - Nord America 3.278
AS - Asia 1.247
AF - Africa 115
OC - Oceania 15
SA - Sud America 11
Continente sconosciuto - Info sul continente non disponibili 4
Totale 8.227
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.237
IT - Italia 1.034
DE - Germania 809
SE - Svezia 640
CN - Cina 538
SG - Singapore 334
IE - Irlanda 267
UA - Ucraina 174
ID - Indonesia 170
FR - Francia 161
GB - Regno Unito 123
CI - Costa d'Avorio 112
RU - Federazione Russa 104
FI - Finlandia 76
IN - India 64
PL - Polonia 40
TR - Turchia 39
BE - Belgio 28
CA - Canada 27
ES - Italia 25
VN - Vietnam 25
NL - Olanda 20
JP - Giappone 17
AU - Australia 15
TW - Taiwan 14
HK - Hong Kong 13
MX - Messico 13
IR - Iran 12
RO - Romania 11
KR - Corea 8
CZ - Repubblica Ceca 7
PT - Portogallo 7
BR - Brasile 6
CH - Svizzera 6
GR - Grecia 6
BA - Bosnia-Erzegovina 4
IL - Israele 4
NO - Norvegia 4
AT - Austria 3
EU - Europa 2
HR - Croazia 2
LB - Libano 2
SA - Arabia Saudita 2
A1 - Anonimo 1
A2 - ???statistics.table.value.countryCode.A2??? 1
BD - Bangladesh 1
BG - Bulgaria 1
BO - Bolivia 1
BY - Bielorussia 1
BZ - Belize 1
CL - Cile 1
CO - Colombia 1
CY - Cipro 1
DK - Danimarca 1
EC - Ecuador 1
GH - Ghana 1
HU - Ungheria 1
KE - Kenya 1
KZ - Kazakistan 1
MK - Macedonia 1
PH - Filippine 1
RS - Serbia 1
TH - Thailandia 1
VE - Venezuela 1
ZA - Sudafrica 1
Totale 8.227
Salva come PNG Salva come JPEG
Città #
Chandler 629
Ashburn 293
Singapore 257
Dublin 248
Jakarta 168
San Mateo 129
Wilmington 125
Jacksonville 114
Abidjan 112
Nanjing 111
Milan 108
Dearborn 106
Princeton 93
Ann Arbor 91
Rome 90
Boston 88
Beijing 81
Moscow 73
Cattolica 66
Woodbridge 65
Redwood City 61
Fairfield 58
Nürnberg 50
New York 46
Seattle 41
Houston 40
Nanchang 40
Warsaw 38
Lawrence 35
Redmond 35
Marseille 34
Boardman 30
Naples 28
Bremen 27
Izmir 27
Shenyang 27
Mountain View 26
Norwalk 26
Shanghai 25
Changsha 23
Hangzhou 23
Helsinki 23
Los Angeles 23
Bari 21
Tianjin 21
Brussels 20
Kunming 20
Guangzhou 17
Hebei 17
Cambridge 16
London 16
Detroit 15
Lancaster 15
Dong Ket 14
Hefei 14
Jiaxing 13
San Jose 13
Chicago 12
Fremont 12
Leawood 12
San Diego 12
Leicester 11
University Park 11
Zhengzhou 11
Hanoi 10
Mascalucia 10
Munich 10
Washington 10
Atlanta 8
Cerveteri 8
Falls Church 8
Montreal 8
Pune 8
Rho 8
Saint Louis 8
Berlin 7
Hong Kong 7
Lappeenranta 7
Palermo 7
Renton 7
Brescia 6
Busto Arsizio 6
Las Vegas 6
Perugia 6
Salerno 6
Simi Valley 6
Taipei 6
Augusta 5
Boscoreale 5
Brno 5
Brugherio 5
Castelfidardo 5
Catania 5
Dallas 5
Fuzhou 5
Granada 5
Istanbul 5
Lanzhou 5
Madrid 5
Messina 5
Totale 4.384
Salva come PNG Salva come JPEG
Nome #
Neuropsichiatria dei disturbi dell’umore. In: Neuroscienze cliniche e del comportamento. Basi neurobiologiche e neuropsicologiche. Psicopatologia funzionale e neuropsichiatria A cura di C. Blundo 514
Effects of stimulation of the subthalamic nucleus on naming and reading nouns and verbs in Parkinson's disease 320
Basi neuro anatomiche delle funzioni cognitive e del comportamento 180
Motor and cognitive outcome in patients with Parkinson's disease 8 years after subthalamic implants 144
Unilateral Extradural Motor Cortex Stimulation is Safe and Improves Parkinson's Disease at 1 Year 136
Sexual Behavior in Women with Bipolar Disorder 133
Cognitive outcome five years after bilateral chronic stimulation of subthalamic nucleus in patients with Parkinson's disease 129
Genetic meta-analysis of diagnosed Alzheimer's disease identifies new risk loci and implicates Aβ, tau, immunity and lipid processing 122
Relationships of Dietary Patterns, Foods, and Micro- and Macronutrients with Alzheimer's Disease and Late-Life Cognitive Disorders: A Systematic Review 121
Treatment of motor and non-motor features of Parkinson's disease with deep brain stimulation 120
Different Cognitive Frailty Models and Health- and Cognitive-related Outcomes in Older Age: From Epidemiology to Prevention 111
Unilateral extradural motor cortex stimulation is safe and improves Parkinson disease at 1 year 109
Extradural motor cortex stimulation improves gait, speech, and language in a patient with pure akinesia 103
Oxidative Stress And Overexpression Of Manganese Superoxide Dismutase In Patients With Alzheimer's Disease. 100
Analysis of blink rate in patients with blepharospasm 99
Long-term outcome of subthalamic nucleus DBS in Parkinson's disease: from the advanced phase towards the late stage of the disease? 99
High frequency extradural motor cortex stimulation transiently improves axial symptoms in a patient with Parkinson's disease 90
APOE epsilon 2/epsilon 4 genotype a risk factor for primary progressive aphasia in women 90
Innovative biomarkers in psychiatric disorders: a major clinical challenge in psychiatry 85
Extradural Motor Cortex Stimulation might improve episodic and working memory in patients with Parkinson’s disease 85
Neuropsychological features of patients with Parkinson’s disease and impulse control disorders 82
Effects of COVID-19 Lockdown on Movement Disorders Patients With Deep Brain Stimulation: A Multicenter Survey 81
Additive Role of a Potentially Reversible Cognitive Frailty Model and Inflammatory State on the Risk of Disability: The Italian Longitudinal Study on Aging. 80
Author Correction: Genetic meta-analysis of diagnosed Alzheimer’s disease identifies new risk loci and implicates Aβ, tau, immunity and lipid processing (Nature Genetics, (2019), 51, 3, (414-430), 10.1038/s41588-019-0358-2) 80
Contribution of Mediterranean Diet in the Prevention of Alzheimer's Disease. 79
Extradural Motor Cortex Stimulation in Parkinson's Disease: Long-Term Clinical Outcome. 79
Rare coding variants in PLCG2, ABI3, and TREM2 implicate microglial-mediated innate immunity in Alzheimer's disease 77
Selective impairment of action-verb naming and comprehension in progressive supranuclear palsy 76
Freezing of gait in Parkinson's disease: the paradoxical interplay between gait and cognition 76
Can a Positive Allosteric Modulation of GABAergic Receptors Improve Motor Symptoms in Patients with Parkinson's Disease? The Potential Role of Zolpidem in the Treatment of Parkinson's Disease 76
New insights into the genetic etiology of Alzheimer's disease and related dementias 76
Sensorial frailty: age-related hearing loss and the risk of cognitive impairment and dementia in later life 75
Italian Frontotemporal Dementia Network (FTD Group-SINDEM): sharing clinical and diagnostic procedures in Frontotemporal Dementia in Italy 74
Selective impairment of action-verb naming and comprehension in progressive supranuclear palsy 73
An Old Challenge with New Promises: A Systematic Review on Comprehensive Geriatric Assessment in Long-Term Care Facilities 73
Early versus delayed bilateral subthalamic deep brain stimulation for Parkinson’s disease: Need for long-term trials. 72
Cognitive and behavioural changes after deep brain stimulation of the subthalamic nucleus in Parkinson’s disease 72
Emerging drugs to reduce abnormal β-amyloid protein in Alzheimer’s disease patients 71
Tau-Centric Targets and Drugs in Clinical Development for the Treatment of Alzheimer's Disease 70
Neuroanatomical Correlates of Category-specific Semantic Disorders: A Critical Survey 69
Common variants in Alzheimer’s disease and risk stratification by polygenic risk scores 68
Suicidal behaviour in older age: A systematic review of risk factors associated to suicide attempts and completed suicides 66
TOMM40, APOE, and APOC1 in Primary Progressive Aphasia and Frontotemporal Dementia 65
Transient mania with hypersexuality after surgery for high frequency stimulation of the subthalamic nucleus in Parkinson's disease 65
Selective impairment of action-verb naming and comprehension in progressive supranuclear palsy 65
Reversible Cognitive Frailty, Dementia, and All-Cause Mortality. The Italian Longitudinal Study on Aging 65
Genetically elevated high-density lipoprotein cholesterol through the cholesteryl ester transfer protein gene does not associate with risk of Alzheimer's disease 65
Tau-based therapeutics for Alzheimer's disease: Active and passive immunotherapy 64
The potential of solanezumab and gantenerumab to prevent Alzheimer’s disease in people with inherited mutations that cause its early onset 63
Cognitive frailty: definitions, components, and impact on disability and mortality 63
Tau-directed approaches for the treatment of Alzheimers disease: Focus on leuco-methylthioninium 62
Effect of a CYP2D6 polymorphism on the efficacy of donepezil in patients with Alzheimer disease 60
FOXP2, APOE, and PRNP: New Modulators in Primary Progressive Aphasia 59
Early visual memory deficits: a neuropsychological marker of GBA mutations in PD? 56
Accelerated Long-Term Forgetting Limited to the Recollection Component of Recognition Memory in a Temporal Lobe Epileptic Patient 56
Psychotropic drugs and CYP2D6 in late-life psychiatric and neurological disorders. What do we know? 56
Zolpidem in Parkinson's disease 55
Functional disorders after COVID-19 vaccine fuel vaccination hesitancy 55
Biopsychosocial frailty and the risk of incident dementia: The Italian longitudinal study on aging 54
Development of disease-modifying drugs for frontotemporal dementia spectrum disorders 53
The Challenge of Antidepressant Therapeutics in Alzheimer's Disease 51
Phytochemicals in the Treatment of Alzheimer's Disease: A Systematic Review 49
Role of CLU, PICALM, and TNK1 Genotypes in Aging With and Without Alzheimer's Disease 49
APOE ε2-ε4 genotype is a possible risk factor for primary progressive aphasia [6] 49
Social Frailty in the COVID-19 Pandemic Era 49
Clinical Indicators of Oral Frailty: A Domain-specific Frailty Phenotype 49
Early rightwards orienting of attention on simple reaction time performance in patients with left-sided neglect 48
Oral frailty and its determinants in older age: a systematic review 48
Physical Frailty, Multimorbidity, and All-Cause Mortality in an Older Population From Southern Italy: Results from the Salus in Apulia Study 48
Nutritional Intervention as a Preventive Approach for Cognitive-Related Outcomes in Cognitively Healthy Older Adults: A Systematic Review 47
Botulinum Toxin Type A for the Treatment of Lower Limb Spasticity after Stroke 47
Clusters of cognitive and behavioral disorders clearly distinguish primary progressive aphasia from frontal lobe dementia, and Alzheimer's disease 47
Polymorphism C in the serotonin 1 transporter gene in depression-free elderly patients with vascular dementia 47
Malattia di Parkinson e altri disordini del movimento 47
Pharmacotherapy for the treatment of depression in patients with alzheimer’s disease: a treatment-resistant depressive disorder 46
Disproportionate Impairment in Naming and Comprehension of Nouns with Relative Sparing of Verbs in a Patient who Survived Herpes Simplex Encephalitis 46
Anti-amyloid-β protein agents for the treatment of Alzheimer’s disease: an update on emerging drugs 46
Can pharmacotherapy effectively reduce Alzheimer’s related agitation? 46
The diagnostic accuracy of late-life depression is influenced by subjective memory complaints and educational level in an older population in Southern Italy 46
Apolipoprotein E ε4 allele differently affects the patterns of neuropsychological presentation in early- and late-onset Alzheimer's disease patients 45
CYP2D6 genotypes in revolving door patients with bipolar disorders: A case series 44
Estimating the Inheritance of Frontotemporal Lobar Degeneration in the Italian Population 43
Psychiatry meets pharmacogenetics for the treatment of revolving door patients with psychiatric disorders 43
Normal pressure hydrocephalus 42
The role of biomarkers in psychiatry 42
Promising therapies for the treatment of frontotemporal dementia clinical phenotypes: from symptomatic to disease-modifying drugs 41
Multiple personality and hallucinations in a patient with normal dat-scan spect fulfilling diagnostic criteria for probable dementia with lewy bodies 41
Disturbi cognitivi e comportamentali nella malattia di Parkinson 41
The relationship between epigenetics and microbiota in neuropsychiatric diseases 40
Processed meat consumption and the risk of incident late-onset depression: a 12-year follow-up of the Salus in Apulia Study 40
Are apolipoprotein E fragments a promising new therapeutic target for Alzheimer's disease? 40
Obsessive-compulsive behaviour and cognitive impairment in a parkinsonian patient after left putaminal lesion 39
High doses of incobotulinumtoxinA for the treatment of post-stroke spasticity: are they safe and effective? 39
The RELN locus in Alzheimer's Disease 39
Cognitive frailty: a potential target for secondary prevention of dementia 38
Corrigendum to "Nutritional interventions and cognitive-related outcomes in patients with late-life cognitive disorders: A systematic review" Neurosci. Biobehav. Rev. 95 (2018) 480-498 38
Disease-modifying therapies for tauopathies: agents in the pipeline 37
The need of an extensive neuropsychological assessment for a reliable diagnosis of mild cognitive impairment in patients with Parkinson's disease 36
In vivo cholinergic circuit evaluation in frontotemporal and Alzheimer dementias 35
Vitamin D in the development and progression of alzheimer’s disease: implications for clinical management 35
Totale 7.359
Salva come PNG Salva come JPEG
Categoria #
all - tutte 45.217
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 45.217
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020634 0 0 0 0 76 100 78 35 93 80 111 61
2020/2021843 44 60 24 53 68 51 141 60 105 133 69 35
2021/20221.109 82 75 31 71 114 50 28 156 65 53 175 209
2022/20232.106 234 239 171 233 180 258 190 146 249 69 64 73
2023/20241.317 71 360 58 60 77 124 120 51 31 45 149 171
2024/2025550 55 54 202 104 135 0 0 0 0 0 0 0
Totale 8.658